HDAC9 and triple-negative breast carcinoma: Most recently, we further demonstrated that differentiated triple-negative breast cancer cells can be reprogrammed to become quiescent resistant stem-like cancer cells through exposure to cancer-targeting agents like HDAC inhibitors [17].